1. Home
  2. ETON vs TUSK Comparison

ETON vs TUSK Comparison

Compare ETON & TUSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • TUSK
  • Stock Information
  • Founded
  • ETON 2017
  • TUSK 2014
  • Country
  • ETON United States
  • TUSK United States
  • Employees
  • ETON N/A
  • TUSK N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • TUSK Oilfield Services/Equipment
  • Sector
  • ETON Health Care
  • TUSK Energy
  • Exchange
  • ETON Nasdaq
  • TUSK Nasdaq
  • Market Cap
  • ETON 199.5M
  • TUSK 211.8M
  • IPO Year
  • ETON 2018
  • TUSK 2016
  • Fundamental
  • Price
  • ETON $10.02
  • TUSK $3.18
  • Analyst Decision
  • ETON Strong Buy
  • TUSK
  • Analyst Count
  • ETON 3
  • TUSK 0
  • Target Price
  • ETON $12.00
  • TUSK N/A
  • AVG Volume (30 Days)
  • ETON 212.9K
  • TUSK 102.9K
  • Earning Date
  • ETON 11-12-2024
  • TUSK 11-01-2024
  • Dividend Yield
  • ETON N/A
  • TUSK N/A
  • EPS Growth
  • ETON N/A
  • TUSK N/A
  • EPS
  • ETON N/A
  • TUSK N/A
  • Revenue
  • ETON $34,677,000.00
  • TUSK $187,514,000.00
  • Revenue This Year
  • ETON $19.61
  • TUSK N/A
  • Revenue Next Year
  • ETON $82.71
  • TUSK $2.48
  • P/E Ratio
  • ETON N/A
  • TUSK N/A
  • Revenue Growth
  • ETON 5.64
  • TUSK N/A
  • 52 Week Low
  • ETON $3.03
  • TUSK $2.50
  • 52 Week High
  • ETON $11.11
  • TUSK $4.95
  • Technical
  • Relative Strength Index (RSI)
  • ETON 67.30
  • TUSK 26.29
  • Support Level
  • ETON $8.76
  • TUSK $3.40
  • Resistance Level
  • ETON $11.11
  • TUSK $3.74
  • Average True Range (ATR)
  • ETON 0.66
  • TUSK 0.22
  • MACD
  • ETON 0.10
  • TUSK -0.08
  • Stochastic Oscillator
  • ETON 62.02
  • TUSK 2.27

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated, growth oriented energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. Its suite of services includes well-completion services, infrastructure services, natural sand proppant services, drilling services, and other services. The majority of revenues are earned from the well-completion services and geographically from the United States followed by Canada and other countries.

Share on Social Networks: